Successful demonstration of cationic lipid-mediated gene transfer into a variety of cells in vitro has generated considerable interest in achieving an optimal condition for in vivo transfection. After the initial studies by Brigham et al 1 2 who demonstrated successful transfection of cells in the lung, heart, liver, spleen and kidney by tail vein injection of DNA/lipid complexes, significant efforts have been directed at improving the transfection activity of cationic lipid-based gene carriers in vivo through intravenous administration. It has been shown [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] that the level of transgene expression after intravenous injection of DNA/lipid complexes can be significantly increased through optimization of the physicochemical properties of DNA/lipid complexes which include: (1) the cationic lipid to DNA ratio, (2) the diameter of lipid particles, and (3) the inclusion of helper lipids. While the in vivo results indicated the importance of physical properties of DNA/lipid complexes in transfection, an equally important conclusion derived from these studies is that the structure of cationic lipid also has an important influence in the in vivo transfection activity.
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A good example for demonstrating the importance of lipid structure to the in vivo transfection comes from a previous study, 4 in which N- [1-(2,3-dioleyloxy) propyl]-N,N,N-trimethylammonium chloride (DOTMA) and N- [1-(2,3- 
dioleoyloxy)propyl]-N,N,N-trimethylammonium (DOTAP), the two most commonly used cationic
Correspondence: D Liu Received 27 September 1999; accepted 22 December 1999 share the following structural characteristics: (1) cationic head group and its neighboring aliphatic chain being in a 1,2-relationship on the backbone; (2) ether bond for bridging the aliphatic chains to the backbone; and (3) paired oleyl chains as the hydrophobic anchor. Cationic lipids without these structural features had lower in vivo transfection activity. These structural characteristics, however, did not significantly influence their in vitro transfection activity. The contribution that cationic lipids make to the overall in vivo transfection activity is likely to be determined by the structure of DNA/lipid complexes and by the outcome of the interaction between the DNA/lipid complexes and blood components upon intravenous administration. Gene Therapy (2000) 7, 764-768.
lipids for transfection, [17] [18] [19] were systematically evaluated for their in vivo transfection activity. It was found that DOTMA and DOTAP, which differ in the linkage bonds (two ether bonds in DOTMA and two ester bonds in DOTAP), are equally active in transfecting many types of cells in vitro but exhibit a 10-fold difference in the level of transgene expression in the animal lung after intravenous administration. 4 These results form the basis of the present study in which an attempt has been made to identify the structural characteristics of DOTMA that are critical for its higher intravenous transfection activity. To achieve this objective, a series of DOTMA and DOTAP analogues were synthesized and evaluated for their in vitro and in vivo transfection activity.
The structure of DOTMA and DOTAP could be looked at as consisting of four different moieties: (1) a quaternary ammonium head group, (2) a glycerol-based backbone, (3) two linkage bonds, and (4) two hydrocarbon chains. Different strategies were used to synthesize several new analogues that resemble the overall structure of DOTMA and DOTAP molecules. 20, 21 The structures of these new cationic lipids are shown in Figure 1 . Compared with the structure of DOTMA, compounds 1a to 1d contain different backbones. Compounds 2a to 2d are DOTAP analogues with various backbones or aliphatic chains. In compounds 3a to 3c, ether and ester bonds have been used to bridge the backbone and the aliphatic chains.
The structural effect of these new cationic lipids on their intravenous transfection activity was examined in mice using a previously established procedure. 3 Data in Figure 2A show that the backbone that connects the cat- ionic head group and the alkylchains plays an important role in determining the overall in vivo transfection activity. An increase in the number of carbons in the backbone from m = 1 (DOTMA) to m = 2 (cationic lipid 1a) or to m = 4 (cationic lipid 1b) resulted in a 50-fold decrease in luciferase activity in the lung. The level of luciferase in other organs including the heart, liver, spleen and kidney also decreased with increase in the length of backbone.
Because of the lower transfection activity seen in cationic lipids 1a,1b that have a longer backbone, it was decided to evaluate whether such a negative impact is solely due to the length of the backbone or is due to the relative location of the hydrophobic moiety to the cationic head group. To test this, compounds 1c,1d in which one aliphatic chain moved from 3 position in 1a to 2 position in 1c, and from 5 position in 1b to 2 position in 1d were synthesized. The resulting lipids 1c,1d contain the quaternary amine head group and their neighboring alkyl chain in a 1,2-relationship. Transfection activity of cationic lipids 1c,1d ( Figure 2B ) showed the restoration of the transfection activity due to change of position of the hydrophobic moiety in the backbone region. An identical level of luciferase gene expression was obtained in all internal organs of animals transfected with lipid 1c or 1d. The gene expression level was the same as that in animals transfected with DOTMA. These results suggest that the position of the aliphatic chain with respect to the polar head group is critical for transfection activity. Moreover, a lipid with a structure that has the quaternary amine and its neighboring hydrocarbon chain in a 1,2-fashion exhibits higher transfection activity. It is possible that a close proximity of the hydrophobic chains with the cationic head group is critical for the formation of a DNA/lipid complex structure that is more active in intravenous transfection.
The experiments summarized in Figure 2C were designed to evaluate the transfection effect of backbone length, and the relative position of one of the two aliphatic chains to the cationic head group in cationic lipids containing ester bonds. While lipid 2b showed a slightly higher transfection activity than DOTAP, cationic lipid 2a exhibited transfection activity similar to that of DOTAP. These results suggest that the length of the backbone and the relative position of the acyl chains to the cationic head group of cationic lipids with ester linkage bond do not significantly alter the transfection activity, indicating that the positional effect seen in Figure 1A appears unique to cationic lipids with two ether bonds.
One common feature in the more commonly used cationic lipids, which contain either alkyl or acyl chains as a hydrophobic anchor, is that the two aliphatic chains are identical. 22, 23 To explore whether such uniformity is critical for transfection activity, diester cationic lipids 2c,2d in which one aliphatic chain is oleoyl and the other is either a palmitoyl or a lauroyl chain were synthesized. Data in Figure 3A show that uniformity of aliphatic chains is pivotal with regard to the overall transfection activity. Cationic lipids 2c,2d with two different acyl chains showed a lower transfection activity, compared to that of lipid 2b, which possessed two identical aliphatic chains. Similarly, cationic lipids 3b,3c with different aliphatic lengths and ether/ester linkage, showed lower transfection activity in comparison with cationic lipid 3a, which contains two identical hydrocarbon chains ( Figure 3B ). These results support the previously demonstrated findings that the composition of the hydrocarbon chains plays an important role in determining the ultimate transfection activity. 7, 13 As far as transfection activity is concerned, the linkage bond in cationic lipids 2b,2c and 3b,3c does not seem to be important, since a similar level of transgene expression was seen in animals transfected with cationic lipids containing either two ester bonds ( Figure 3A) or ether/ester bonds ( Figure 3B) .
Additional experiments were performed with cationic lipid 1c to evaluate the extent to which cationic lipid to DNA ratio affects the in vivo transfection activity. Various buffer systems have been used by different investigators in the preparation of DNA/lipid complexes. 2, 7, 14 Therefore, DNA/lipid complexes were prepared in phosphatebuffered saline (PBS, pH 7.6), 5% glucose, distilled water, or Hepes (pH 7.5) buffer. A standard intravenous transfection test was performed in mice using 25 g of pCMVLuc plasmid DNA in the presence of different amounts of cationic lipids. Data summarized in Figure 4 show that cationic lipid to DNA ratio has an important effect on the level of transgene product. For example, at the ratio of 36:1, the level of luciferase gene expression in the lung was of similar magnitude regardless of the type of buffer used. However, at a lower cationic lipid to DNA ratio, an obvious difference in luciferase level in the lung was seen in animals transfected with DNA/lipid complexes prepared in different solutions. While a comparable level of luciferase gene expression at cationic lipid to DNA ratio of 12:1 to that of 36:1 was observed in DNA/lipid complexes prepared in PBS for DOTMA and lipid 1c, a much lower level of luciferase gene expression was seen in animals transfected with complexes prepared in Hepes buffer, 5% glucose solution or distilled water. These results suggest that while an optimal transfection activity can be obtained by using a higher cationic lipid to DNA ratio, selection of an appropriate solution for preparation of DNA/lipid complexes may become critical when a small amount of cationic lipids has to be used.
Considering that the in vivo environment where gene transfer occurs is different from that of a cell culture system, whether the structure-activity relationship seen in vivo is comparable with that seen in vitro was evaluated. For this purpose, transfection was performed on five different cell lines using cationic lipids that exhibited difference in in vivo transfection activity with intravenous administration. Data summarized in Figure 5A show that although different levels of gene product were obtained in different cell lines, the major factor that determined the level of gene expression was the cell line. Among the cell types tested, 293 cells derived from human embryonic kidney showed a significantly higher level of gene expression followed by BL-6 cells (murine melanoma). A much lower level of gene expression was obtained in HepG2 liver cells, NIH 3T3 and Hela cells. Interestingly, no clear-cut pattern emerged regarding the structureactivity relationship among the cationic lipids tested. Cationic lipids with different backbones, aliphatic chains and linkage bonds exhibited similar transfection activity in a given cell type. In addition, the transfection activity of the new cationic lipids was almost identical to that of DOTMA or DOTAP. The total protein recovery from the transfected cells ( Figure 5B ) by these new lipids was either similar to or higher than those of cells transfected with either DOTMA or DOTAP, suggesting that none of these new lipids has any significant toxic effect on these cells. Cationic lipids that have been developed to date invariably consist of three structural components: (1) a cationic head group, (2) backbone, and (3) hydrophobic anchor. 24 While many of the cationic lipids, including the hydrocarbon chain-based 13, 18, 19, [25] [26] [27] [28] [29] and cholesterolbased, [30] [31] [32] showed good transfection activities in vitro, other studies have shown that hydrocarbon chain-based cationic lipids with quaternary ammonium moiety as the head group exhibit better intravenous transfection activity. 33 Results from our previous studies designed to identify the factors that control the intravenous transfection activity of cationic lipids showed that DOTMA appeared to be the most active lipid in transfecting lung endothelial cells in mice via tail vein administration of DNA/lipid complexes. 3, 4 The results summarized in this report further support this claim.
While the evidence presented here clearly supports the Gene Therapy notion that the structure of cationic lipids plays a critical role in determining the magnitude of their transfection activity in vivo, the mechanisms by which the overall transfection activity is regulated by the lipid structure remains to be explored. Lack of a significant difference in transfecting activity of these DOTMA analogues with a cell line in vitro may suggest that the structure-activity relationship observed in vivo is not due to the cells transfected in vivo, but rather due to the conditions where transfection occurs. In general, upon entering the blood circulation after its intravenous administration, cationic lipid in the form of either free liposomes or as a complex with DNA may interact with negatively charged blood components (cellular and non-cellular). It is possible that such an interaction would produce aggregates involving cationic lipid, DNA and blood components. These aggregates, if large enough, are likely to be trapped in larger blood vessels before reaching the capillary bed, resulting in a limited exposure of DNA molecules to the lung endothelial cells and a low level of transgene expression. Similarly, the negatively charged blood components may compete with DNA for binding to cationic liposomes, such that DNA molecules are released from the DNA/lipid complexes prematurely. This would result in a transient exposure of DNA molecules to the lung endothelium, with minimal success of transfection. The best cationic lipid structure for intravenous transfection, however, is the one with: (1) hydrocarbon chains adjacent to the cationic head group, (2) ether bonds for bridging the hydrocarbon chains to backbone, and (3) a pair of oleyl chains as the hydrophobic anchor.
In summary, we have demonstrated in this study that the structural characteristics of DOTMA for its higher transfection activity include the close proximity of its hydrocarbon chains to the cationic head group, its two ether bonds, and paired oleyl chains as the hydrophobic anchor. Although changes in these structures do not affect the in vitro transfection activity, they do in fact decrease intravenous transfection activity.
